Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1999 Mar;115(3):443–450. doi: 10.1046/j.1365-2249.1999.00815.x

Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts

T Messele *, M Abdulkadir *, A L Fontanet *, B Petros *, D Hamann , M Koot , M T L Roos , P T A Schellekens , F Miedema , T F Rinke De Wit *
PMCID: PMC1905237  PMID: 10193416

Abstract

To assess possible differences in immune status, proportions and absolute numbers of subsets of CD4+ and CD8+ T cells were compared between HIV healthy Ethiopians (n = 52) and HIV Dutch (n = 60). Both proportions and absolute numbers of naive CD4+ and CD8+ T cells were found to be significantly reduced in HIV Ethiopians compared with HIVDutch subjects. Also, both proportions and absolute numbers of the effector CD8+ T cell population as well as the CD4+ CD45RACD27 and CD8+ CD45RA CD27 T cell populations were increased in Ethiopians. Finally, both proportions and absolute numbers of CD4+ and CD8+ T cells expressing CD28 were significantly reduced in Ethiopians versus Dutch. In addition, the possible association between the described subsets and HIV status was studied by comparing the above 52 HIV individuals with 32 HIV+ Ethiopians with CD4 counts > 200/μl and/or no AIDS-defining conditions and 39 HIV+ Ethiopians with CD4 counts < 200/μl or with AIDS-defining conditions. There was a gradual increase of activated CD4+ and CD8+ T cells, a decrease of CD8+ T cells expressing CD28 and a decrease of effector CD8+ T cells when moving from HIV to AIDS. Furthermore, a decrease of naive CD8+ T cells and an increase of memory CD8+ T cells in AIDS patients were observed. These results suggest a generally and persistently activated immune system in HIVEthiopians. The potential consequences of this are discussed, in relation to HIV infection.

Keywords: Ethiopia, HIV-1, T cells, naive cells, activation

INTRODUCTION

HIV infection is associated with profound changes in various T cell subsets of the immune system [15]. Loss of CD4+ T cells is known to be the hallmark of HIV infection and it is a well accepted laboratory marker of HIV disease progression [6,7]. Also, changes in other T cell subsets have been implicated in HIV+ persons from studies in Europe and North America: expansion of CD8+ T cells [8], loss of naive CD8+ T cells, increase of both CD4+ and CD8+ T cell memory subsets [9,10] and increased activated CD4+ and CD8+ T cell subsets [1116].

In Africa, HIV infection is spreading fast and has become one of the major causes of mortality [17,18]. Studies have suggested that HIV disease progression is faster in Africa when compared with industrialized countries [19]. Pre-existent immune activation as a result of highly prevalent infectious diseases and also nutritional factors have been suggested as important contributors to this altered HIV disease progression in Africa [2024]. There are not many reports detailing the immune status of HIV-infected and non-infected Africans. Moreover, studies on the immunological markers which are important for predicting HIV disease progression in Africans are scarce. We previously reported that CD4 counts are significantly lower and CD8 counts are higher in HIV Ethiopians compared with Dutch HIV controls (Tsegaye et al., submitted). In this study we compare several CD4+ and CD8+ T cell subsets in Ethiopian and Dutch HIVindividuals. In addition, a cross-sectional study is performed to assess the association of several CD4+ and CD8+ T cell subsets with defined stages of HIV infection in Ethiopian individuals.

SUBJECTS AND METHODS

Subjects

For comparison of Ethiopian and Dutch subjects, 52 HIVhealthy Ethiopians and 60 HIV healthy Dutch individuals were included. Two additional groups of Ethiopian subjects were included in a cross-sectional study: 32 HIV+ with CD4 counts > 200/μl and no AIDS-defining conditions (designated in this study as HIV+) and 39 HIV+ patients with CD4 counts < 200 μl or exhibiting AIDS-defining conditions based on the WHO staging system for HIV infection and disease [25] (designated in this study as AIDS). The HIV and HIV+ groups are residents of a suburb of Addis Ababa and factory workers participating in a cohort study presently performed in Akaki, a village 15 km to the south-east of Addis Ababa, the capital of Ethiopia. Subjects of the AIDS group were patients hospitalized in Addis Ababa. All the study subjects gave their informed consent.

Testing of samples

The samples from the Ethiopian subjects were analysed at the ENARP laboratory in Addis Ababa, Ethiopia, and samples from the Dutch subjects were analysed at the clinical viro-immunology department, CLB, Amsterdam. The two laboratories are collaborating labs within ENARP. Similar protocols of sample processing and testing are used in both laboratories. Furthermore, samples are shared between both laboratories for quality control purposes.

Three-colour immunophenotyping of lymphocyte subsets

In vivo activated, non-activated, naive and memory CD4+ and CD8+ T cells were quantified by three-colour flow cytometric staining using perdinyl chlorophyll-A protein (PerCP)-conjugated CD4 or CD8 MoAbs in combination with PE-conjugated HLA-DR and FITC-conjugated CD38 MoAbs and PerCP-conjugated CD4 or CD8 MoAbs in combination with PE-conjugated CD27 and FITC-conjugated CD45RA MoAbs, respectively. All the MoAbs were purchased from Becton Dickinson (San Jose, CA), except the CD38 MoAb, which was purchased from Immunotech (Marseille, France). The immunophenotyping was performed on whole blood. EDTA blood (100 μl) was incubated with each combination of MoAbs for 15–20 min at room temperature in the dark. Erythrocyte lysing was done by adding 2 ml lysing solution per tube (FACSlyse; Becton Dickinson) and incubating for 10 min at room temperature in the dark. The cells were centrifuged at 300 g for 5 min and then washed twice with Isoton (Becton Dickinson). The stained samples were analysed the same day using a FACScan flow cytometer with Cellquest software (Becton Dickinson). A live gate was set around the CD4+ and CD8+ cells in order to acquire a minimum of 1500 CD4 or CD8 cells for analysis.

Statistical analysis

Statistical analyses were performed using the STATA program (Stata Corp., TX) The distribution of T cell subset proportions was compared between two groups using non-parametric methods (Mann–Whitney U-test). When comparisons involved three groups (Ethiopian HIV, HIV+ and AIDS) the level of significance (α) was adjusted using the Bonferroni correction (α = 0.033).

RESULTS

Naive, memory and effector T cell subsets compared between HIV Ethiopian and Dutch subjects

Naive, memory and effector CD4+ and CD8+ T cells were measured using a combination of CD45RA and CD27 MoAbs, according to Hamann et al. [26]. Table 1 shows both the proportions and absolute values of CD4+ and CD8+ T cell subsets in 52 HIV Ethiopian versus 60 HIV Dutch subjects.

Table 1.

Proportions and absolute numbers of T cell subsets in HIV Ethiopian and Dutch individuals

graphic file with name cei0115-0443-t1.jpg

Both proportions and absolute values of CD4+ T cells were significantly decreased in Ethiopians compared with the Dutch subjects. Proportions of CD8+ T cells were increased in Ethiopians, with borderline significance for absolute values. As a consequence, the CD4/8 ratios of HIVhealthy Ethiopians were low.

The proportions and absolute values of both CD4+ and CD8+ naive (CD45RA+CD27+) T cells were significantly reduced in Ethiopians compared with Dutch subjects. In contrast, the proportions and absolute values of both CD4+ and CD8+ memory (CD45RACD27) T cells were increased in Ethiopians. For the second memory subset (CD45RACD27+), the absolute values were decreased, both in CD4+ and CD8+ T cells of Ethiopians. This decrease was also reflected in the proportions of the pertinent CD8+ memory subset, but not of the CD4+ subset. Both proportions and absolute values of CD8+ cytotoxic effector T cells were increased in Ethiopians compared with the Dutch subjects. Finally, both proportions and absolute values of CD4+ and CD8+ T cells expressing CD28 were decreased in Ethiopians versus Dutch.

The combination of the above observations points towards a highly activated immune status of HIV Ethiopian versus HIV Dutch individuals.

Naive, memory and effector T cell subsets in Ethiopian HIV, HIV+ and AIDS subjects

In order to assess the effect of HIV infection on the above-defined immune status of Ethiopian individuals, a cross-sectional study was performed, comparing three groups of subjects. A provisional classification is used in this study, naming HIV non-infected individuals ‘HIV’, HIV-infected individuals with CD4+ T cell counts > 200/μl and no AIDS-defining conditions ‘HIV+’, and HIV-infected individuals with CD4+ T cell counts < 200/μl or AIDS-defining conditions ‘AIDS’.

Table 2 presents the median age, the male-to-female ratio, the proportions and absolute values of lymphocytes, CD4+, CD8+ T cell subsets and the CD4/CD8 ratios of 123 Ethiopian individuals, grouped according to the above HIV status designation. Figure 1a,b depict representative dot plot analyses of changes in CD45RA/CD27 proportions of the various T cell subsets, according to HIV status, as defined above.

Table 2.

Characteristics of study populations, designated HIV, HIV+ and AIDS

graphic file with name cei0115-0443-t2.jpg

Fig. 1.

Fig. 1

Examples of dot plots of CD4+ and CD8+ T cell subsets in the three groups of Ethiopians (HIV, HIV+ and AIDS). CD4+ and CD8+ T cell subsets are defined as follows: activated (HLA-DR+CD38+), resting (HLA-DR CD38), ‘non-progression associated’ (HLA-DR+CD38), naive (CD45RA+CD27+), memory (CD45RA CD27+), effector (CD45RA+CD27) and memory + effector (CD45RA CD27).

Table 3a summarizes the observations for subsets defined by CD45RA and CD27 MoAbs. Absolute values of naive (CD45RA+CD27+) CD4+ and CD8+ T cells were significantly reduced only in the AIDS group (for CD8+ T cells this also applied to proportions). The Th2 cell containing memory (CD45RACD27) CD4+ T cells [27,28] were reduced in absolute numbers in HIV+ and AIDS patients, but remained stable in proportions, comparing the three groups of subjects. The equivalent CD8+ memory T cells were increased in proportions in the AIDS group compared with the HIV group, whereas the absolute values remain unchanged in the three groups. The second subset of memory (CD45RACD27+) CD4+ T cells showed identical patterns to the specialized memory CD4+ T cells. However, the memory (CD45RACD27+) CD8+ T cells showed a significant increase in absolute numbers in the HIV+ group compared with the two other groups, while this was not reflected in their proportions. The cytotoxic effector (CD45RA+ CD27) CD8+ T cell proportions were significantly reduced in both HIV+ and AIDS groups compared with the HIV group. The absolute values of this subset were only significantly decreased in the AIDS group. Both absolute values and proportions of CD4+ T cells expressing these markers were very low in all groups.

Table 3.

Proportions and absolute numbers of T cell subsets in Ethiopian HIV, HIV+ and AIDS groups. a. CD45RA, CD27 subpopulations

graphic file with name cei0115-0443-t3.jpg

The CD28 costimulatory molecule in Ethiopian HIV, HIV+ and AIDS subjects

The percentages of CD4+ T cells expressing CD28 were equally high in the HIV, HIV+ and AIDS groups, whereas the absolute values showed a decrease from HIV to HIV+ to AIDS. As shown in Table 3a, the proportions of CD8+ T cells expressing CD28 were significantly reduced in the AIDS group. When absolute values were assessed, this particular CD8+ T cell subset showed a significant increase in HIV+versus HIVsubjects and a decrease in the AIDS group.

Activated and resting T cell subsets in Ethiopian HIV, HIV+, AIDS subjects

Activated and resting T cell subsets were measured using a combination of HLA-DR and CD38 MoAbs, as described [12,14]. Figure 1c,d depict representative dot plot analyses of the changes in CD38/HLA-DR proportions according to HIV status. Table 3b summarizes the observations.

Proportions of activated (HLA-DR+ CD38+) T cells of both CD4+ and CD8+ T cells were increased from HIV to HIV+ to AIDS groups. This increment was more pronounced for CD8+ T cells than for CD4+ T cells. For absolute values, there was an increase of activated CD4+ and CD8+ T cells in HIV+versus HIV subjects. However, in the AIDS group there was no further increase of these T cell populations. Conversely, the proportions and absolute values of resting (HLA-DRCD38) T cells of both CD4+ and CD8+ subsets were decreased from HIV to HIV+ to AIDS. The proportions of CD4+ and CD8+ T cells expressing CD38 but not HLA-DR were increased in both HIV+ and AIDS groups compared with the HIV group. This was also true for absolute values, with the exception of HLA-DRCD38+CD4+ T cells of AIDS patients compared with HIVindividuals.

Both proportions and absolute values of HLA-DR+CD38 CD8+ T cells were significantly reduced in the AIDS group compared with the HIV and HIV+ groups. There was no significant difference on proportions of CD4+ T cells expressing this marker combination between the three groups studied.

DISCUSSION

In this study we demonstrate that the representation of several T cell subsets is different, comparing HIV Ethiopian and Dutch subjects. Most significantly, naive T cells were found to be considerably reduced in healthy HIVEthiopians. The naive T cell subsets are responsible for mounting immune responses to newly encountered antigens and in vitro studies have shown that these cells have a better capacity for proliferation in response to mitogenic stimuli [29]. T cells which were previously shown to be of memory type, in terms of cytokine production and antigen expression [26], were demonstrated to be reduced in Ethiopian CD8+ T cells, but not in CD4+ T cells, compared with the Dutch. The CD8+ effector T cell subset, which was shown to exhibit cytolytic properties and poor responses to most in vitro stimuli [26], was found to be increased in Ethiopians. The latter observation confirms previous reports of increased effector (CD8+CD57+) T cells in Ethiopians [30]. Finally, both CD4+ and CD8+ T cells with CD45RACD27 memory phenotype were found to be significantly increased in Ethiopians compared with the Dutch group. In previous studies the CD45RACD27 T cell subsets have been shown to constitute a very small proportion of T cells and are suggested to arise as a result of repeated antigenic stimulation in vivo [26,31,32]. CD4+CD27 T cells have been shown to be increased in parasitic infections and to contain Th2 cells, producing IL-4 and IL-5 [27,28]. In the present study, this population of T cells was found to be significantly increased in Ethiopians versus Dutch, probably pointing towards a high prevalence of parasitic infections in the studied Ethiopian subjects.

CD28 is a transmembrane glycoprotein that provides an essential costimulatory signal to T cells [33]. CD4+ and CD8+ T cells expressing CD28 were reduced in Ethiopians compared with the Dutch. Loss of CD28 on T cells has been associated with increased cytolytic T cell activity, impaired response to costimulation via B7, anergy to anti-CD3-induced proliferation and also shorter telomere length, which is indicated to be a result of chronic immune system activation [26,3439].

The above observations reflect a generally and persistently activated immune system in Ethiopians. This activation has been attributed to an increased load of environmental pathogens, especially intestinal parasites in Ethiopia, compared with industrialized countries [20]. The activated state of the immune system in Ethiopians is reflected by increased effector CD8+ T cells, increased T cells associated with repeated antigenic stimulation (containing Th2 cells). The increase of these subsets is at the expense of memory CD8+ T cells, as well as naive T cells and finally T cells expressing CD28 costimulatory molecules in general. This would predict that, as a consequence, the immune system of Ethiopians most probably has a reduced ability to build effective immune responses to newly encountered infections. Also, the immune response against recurrent infections could be impaired. It has been suggested that the HIV-1 co-receptor CCR-5 is more abundantly expressed on memory T cells than on naive T cells [40]. In this light, it can be speculated that the observed reduction in the ratio of naive/memory CD4+ T cells in Ethiopians versus Dutch will potentially increase the proportion of CD4 T cells expressing CCR-5 and thus might facilitate infection of CD4 T cells of Ethiopians with HIV-1. In addition, the increase of effector CD8+ T cells in HIV Ethiopians versus HIV Dutch could result in increased production of cytokines such as tumour necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ), potentially stimulating HIV-1 replication after infection. The above assumptions could contribute to the reported faster progression of HIV-1 infection in an African context [19,20].

In light of this, the observations on the three groups designated HIV, HIV+ and AIDS in this study could be interpreted as follows. Although in general Ethiopians already harbour less naive CD4+ and CD8+ T cells than the Dutch, there was no further proportional decrease of these cells after HIV infection. Only at AIDS was a significant further decrease of naive CD8+ T cells observed. In contrast to previous reports [9], we did not observe significant changes in the proportion of naive CD4 subsets in the three groups of Ethiopians that were compared. The memory CD8+ T cell subset, being smaller in HIV Ethiopians than in the Dutch, was found to be increased in HIV+ and AIDS Ethiopians. Conversely, the effector CD8+ T cell subset, being higher in HIV Ethiopians than in HIV Dutch, decreased in Ethiopian HIV+ and AIDS subjects. This could result in less production of CCR-5 ligands (MIP-1a, MIP-1b, RANTES) and thus the potential inhibitory effect on HIV-1 cell entry would be decreased [41].

The reduced CD28-expressing subsets of HIVEthiopians versus HIV Dutch were only further lost at AIDS for CD8+ T cells. No differences in proportions of CD4+ T cells expressing this marker were observed. This is in agreement with previous reports which showed that hyporesponsiveness of T cells during HIV infection to costimulatory signals is limited to the CD8+ T cell subset and the response of CD4+ T cells is intact [42].

The activated T cell subsets co-expressing CD38 and HLA-DR were found to increase, on both CD4+ and CD8+ T cell subsets, when comparing the HIV, HIV+ and AIDS groups. The opposite was true for resting T cell subsets. The observation that CD8+ T cells expressing only HLA-DR but not CD38 are lost in Ethiopian AIDS patients is in agreement with a previous prospective study which demonstrated that the presence of this subset is associated with long-term survival and stable CD4+ T cell counts [14]. Apart from being an activation marker, CD38 is also detected in immature cells [43].The representation of CD4+ and CD8+ T cells expressing only CD38 but not HLA-DR is increased in both HIV+ and AIDS groups compared with the HIVgroup. This observation may reflect that in HIV infection, apart from immune activation, there is also an increased flow of immature cells into the periphery due to accelerated destruction and replacement of mature T cells (see also [44]).

In conclusion, several of the presently used T cell subset markers could be of predictive value for HIV-1 progression in Ethiopians. However, the value of these markers remains to be evaluated in future prospective studies.

Acknowledgments

This study is part of the Ethio-Netherlands AIDS Research Program (ENARP), a collaborative effort of the Ethiopian Health and Nutrition Research Institute (EHNRI), the Amsterdam Municipal Health Service (GG/GD), the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB) and the Academic Medical Centre of the University of Amsterdam (AMC). ENARP is financially supported by the Netherlands Ministry of Foreign Affairs and the Ethiopian Ministry of Health (MOH) as a bilateral project.

References

  • 1.Roederer M. T-cell dynamics of immunodeficiency. Nature Medicine. 1995;1:621–2. doi: 10.1038/nm0795-621. [DOI] [PubMed] [Google Scholar]
  • 2.Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men. NIAID Multicenter AIDS Cohort Study. Clin Immunol Immunopathol. 1989;52:10–18. doi: 10.1016/0090-1229(89)90188-8. [DOI] [PubMed] [Google Scholar]
  • 3.Roederer M, Herzenberg LA, Herzenberg LA. Changes in antigen densities on leukocyte subsets correlate with progression of HIV disease. Int Immunol. 1995;8:1–11. doi: 10.1093/intimm/8.1.1. [DOI] [PubMed] [Google Scholar]
  • 4.Margolick JB, Donnenberg AD, Munoz A, Park LP, Bauer KD, Giorgi JV, Ferbas J, Saah AJ. Changes in T- and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3− populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J AIDS. 1993;6:153–61. [PubMed] [Google Scholar]
  • 5.Roos MT, Leeuw NASM, Claessen FAP, et al. Viro-immunological studies in acute HIV-1 infection. AIDS. 1994;8:1533–8. doi: 10.1097/00002030-199411000-00003. [DOI] [PubMed] [Google Scholar]
  • 6.Polk BF, Fox R, Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med. 1987;316:61–66. doi: 10.1056/NEJM198701083160201. [DOI] [PubMed] [Google Scholar]
  • 7.De Wolf F, Lange JMA, Houweling JTM, et al. Numbers of CD4+ T-cells and the levels of core antigens and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis. 1988;158:615–22. doi: 10.1093/infdis/158.3.615. [DOI] [PubMed] [Google Scholar]
  • 8.Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990;322:166–72. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  • 9.Roederer M, Gregson Dubs J, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95:2061–6. doi: 10.1172/JCI117892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA, Herzenberg LA. Altered representation of naive and memory CD8 T cell subsets in HIV infected children. J Clin Invest. 1995;95:2054–60. doi: 10.1172/JCI117891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Prince HE, Jensen ER. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. J AIDS. 1991;4:1227–32. [PubMed] [Google Scholar]
  • 12.Autran B, Giorgi JV. Activated CD8+ cells in HIV-related diseases. In: Janossy G, Autran B, Miedema F, editors. Immunodeficiency in HIV infection and AIDS. Basel: Karger; 1992. pp. 171–84. [Google Scholar]
  • 13.Ho HN, Hultin LE, Mitsuyasu RT, et al. Circulating HIV specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol. 1993;150:3070–9. [PubMed] [Google Scholar]
  • 14.Giorgi JV, Ho HN, Hirji K, et al. CD8+ lymphocyte activation at human immunodeficiency virus type 1 serconversion. Development of HLA-DR+ CD38− CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis. 1994;170:775–81. doi: 10.1093/infdis/170.4.775. [DOI] [PubMed] [Google Scholar]
  • 15.Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase P. Selective increase of activation antigens HLA-DR and CD38 on CD4+CD45RO+ T lymphocytes during HIV-1 infection. Clin Exp Immunol. 1994;95:436–41. doi: 10.1111/j.1365-2249.1994.tb07015.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ramzaoui S, Jouen-Beades F, Gilbert D, Borsa-Lebas F, Michel Y, Humbert G, Tron F. During HIV infection CD4+CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+CD38- T-cells. Clin Immunol Immunopathol. 1995;77:33–41. doi: 10.1016/0090-1229(95)90134-5. [DOI] [PubMed] [Google Scholar]
  • 17.Report of the MAP net work symposium. Cote d'Ivoire: Abidijan; Dec 1997. The status and treands of the HIV/AIDS epidemics in sub-Saharam Africa; pp. 3–4. [Google Scholar]
  • 18.Todd J, Balira R, Grosskurth H, et al. HIV-associated adult mortality in a rural Tanzanian population. AIDS. 1997;11:801–7. doi: 10.1097/00002030-199706000-00013. [DOI] [PubMed] [Google Scholar]
  • 19.Anzala OA, Nagelkerke NJ, Bwayo JJ, Holton D, Moses S, Ngugi EN, Ndinya-Achola JO, Plummer FA. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis. 1995;171:686–9. doi: 10.1093/infdis/171.3.686. [DOI] [PubMed] [Google Scholar]
  • 20.Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 1995;16:187–91. doi: 10.1016/0167-5699(95)80119-7. [DOI] [PubMed] [Google Scholar]
  • 21.Rizzardini G, Piconi S, Ruzzante S, et al. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS. 1996;10:1535–42. doi: 10.1097/00002030-199611000-00012. [DOI] [PubMed] [Google Scholar]
  • 22.Weissman D, Barker TD, Fauci AS. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med. 1996;183:687–92. doi: 10.1084/jem.183.2.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Int Med. 1993;153:2149–54. [PubMed] [Google Scholar]
  • 24.Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA. 1993;90:948–52. doi: 10.1073/pnas.90.3.948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.World Health Organization. Weekly epidemiological record. 1990;29:221–4. [Google Scholar]
  • 26.Hamann D, Baars PA, Rep MHG, Hooibrink B, Kerkhof-Garde SR, Klein MR, Van Lier RA. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997;186:1407–18. doi: 10.1084/jem.186.9.1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yazdanbakhsh M, Sartono E, Kruize YC, et al. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol. 1993;23:3312–7. doi: 10.1002/eji.1830231238. [DOI] [PubMed] [Google Scholar]
  • 28.Elson LH, Shaw S, van Lier RA, Nutman TB. T cell subpopulation phenotypes in filarial infections: CD27 negativity defines a population greatly enriched for Th2 cells. Int Immunol. 1994;6:1003–9. doi: 10.1093/intimm/6.7.1003. [DOI] [PubMed] [Google Scholar]
  • 29.Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today. 1988;9:195–9. doi: 10.1016/0167-5699(88)91212-1. [DOI] [PubMed] [Google Scholar]
  • 30.Worku S, Christensson B, Bjorkman A, Islam D. Higher proportion of CD8+ T cells in the blood in healthy adults from Ethiopia and Bangladesh compared with Sweden. Trans Roy Soc Trop Med Hyg. 1997;91:618–22. doi: 10.1016/s0035-9203(97)90051-1. [DOI] [PubMed] [Google Scholar]
  • 31.De Jong R, Brouwer M, Hooibrink B, Van der Pouw Kraan T, Miedema F, Van Lier RA. The CD27 subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol. 1992;22:993–9. doi: 10.1002/eji.1830220418. [DOI] [PubMed] [Google Scholar]
  • 32.Baars PA, Maurice MM, Rep M, Hooibrink B, Van Lier RA. Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27- T cell subset contains specialized primed T cells. J Immunol. 1995;154:17–25. [PubMed] [Google Scholar]
  • 33.Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA. 1990;87:5031–5. doi: 10.1073/pnas.87.13.5031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Vingerhoets JH, Vanham GL, Kestens LL, et al. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV infected subjects. Clin Exp Immunol. 1995;100:425–33. doi: 10.1111/j.1365-2249.1995.tb03717.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Azuma M, Phillips JH, Lanier LL. CD28- T lymphocytes. Antigenic and functional properties. J Immunol. 1993;150:1147–59. [PubMed] [Google Scholar]
  • 36.Borthwick NJ, Bofill M, Gombert WM, et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS. 1994;8:431–41. doi: 10.1097/00002030-199404000-00004. [DOI] [PubMed] [Google Scholar]
  • 37.Brinchmann JE, Dobloug JH, Heger BH, Haaheim M, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection. Functional and clinical correlations. J Infect Dis. 1994;169:730–8. doi: 10.1093/infdis/169.4.730. [DOI] [PubMed] [Google Scholar]
  • 38.Monteiro J, Batliwalla F, Ostrer H, Gregersen PK. Shortened telomers in clonally expanded CD28–CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol. 1996;156:3587–90. [PubMed] [Google Scholar]
  • 39.Effros RB, Allsopp R, Chiu C-P, et al. Shortened telomers in the expanded CD28–CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 1996;10:F17–F22. doi: 10.1097/00002030-199607000-00001. [DOI] [PubMed] [Google Scholar]
  • 40.Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA. 1997;94:1925–30. doi: 10.1073/pnas.94.5.1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rubbert A, Weissman D, Combadiere C, Pettrone KA, Daucher JA, Murphy PM, Fauci AS. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects. AIDS Res Hum Retrovir. 1997;13:63–69. doi: 10.1089/aid.1997.13.63. [DOI] [PubMed] [Google Scholar]
  • 42.Vingerhoets J, Kestens L, Penne G, et al. CD8+ cells and not CD4+ T-cells are hyporesponsive to CD28 and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol. 1997;107:440–7. doi: 10.1046/j.1365-2249.1997.d01-964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA. 1980;77:1588–92. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T-suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J Immunol. 1985;135:1778–85. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES